On Friday, December 11, the U.S. Food and Drug Administration (FDA) announced the approval of the first vaccine for the novel coronavirus that causes COVID-19. Several other vaccine candidates are currently being developed and tested, and multiple vaccines may become available in the weeks and months ahead. In the days to come, myHSteam will reach out to specialists to find out what this means for people with hidradenitis suppurativa (HS).

What myHSteam Members Are Saying About COVID-19 Vaccines

Members of myHSteam share a variety of viewpoints regarding a COVID-19 vaccine. Some are eager to receive it as soon as it becomes available, while others are cautious and waiting to learn more. One member wrote, “Has anyone heard of the effects of the COVID vaccine on HS patients?”

Your doctor knows all the details of your HS, the treatments you take, and other aspects of your health history. This makes them the best source for guidance as you weigh the benefits and risks associated with the vaccine. Many myHSteam members are already talking to their doctors about COVID-19 vaccines. “The next time I can see my doctor I will bring it up,” shared one member.

What Is Known About COVID-19 Vaccines?

The Advisory Committee on Immunization Practices (ACIP) is reviewing clinical trial data on the COVID-19 vaccine to determine whether to recommend it and, if so, who should take it. The ACIP will consider factors like age, underlying medical conditions, race, and ethnicity. With vaccines on the way, people living with HS will need accurate information to make decisions about being vaccinated against the coronavirus.

Here is what is known so far:

• Most COVID-19 vaccines in development require two doses given 21 or 28 days apart. The first approved vaccine, manufactured by Pfizer-BioNTech, requires a second dose 21 days after the first.
• Side effects, which may be worse after the second dose, have been mostly mild or moderate. These include fatigue, muscle and joint soreness, and pain at the injection site.
• Vaccines are being tested in thousands of volunteers to prove their safety and effectiveness before gaining approval.
• Additional safety systems are being put into place to continue monitoring for side effects as vaccines enter public use.
• Vaccine doses will be free for American citizens, but some health care providers may charge for administering them.
• The Centers for Disease Control and Prevention (CDC) recommend health care personnel and residents at long-term care facilities receive access to vaccines first.
• If supplies are limited, older adults and people with specific underlying medical conditions will be considered for early access.
• The federal government is developing a centralized system to distribute and track COVID-19 vaccines.

What Do People With HS Need To Find Out?

There are many questions that remain unanswered, and myHSteam will be reaching out to HS specialists to find out the following:

• Will COVID-19 vaccines be safe for people with HS?
• If there are multiple types of COVID-19 vaccines, will they all be equally safe and effective?
• Will the vaccines be safe and effective for those taking biologics, corticosteroids, or other medications?
• Will people with HS be given priority for vaccinations?
• What is the earliest you could get access to a vaccine?
• Is there any benefit to waiting until later to get a vaccine?

Over the weeks to come, myHSteam will provide updates as we learn more about the safety and effectiveness of COVID-19 vaccines for people with HS, including those treating their skin condition with medications.

What questions do you have about COVID-19 vaccines? Share them in the comments below.